South Africa: Learn about HIV's impact on brain function and cognition with this CPD course. Understand HAND assessment and antiretroviral therapy effects.
Clinical neuropsychologist Digby Ormond-Brown explores the neuropsychological impact of HIV in this specialised course, focusing on its effects on brain function and cognition. After an overview of epidemiology and pathophysiology, he explains HIV-Associated Neurocognitive Disorder, from asymptomatic impairment to HIV-associated dementia, and how it is assessed. The role of biomarkers and possible neuroprotective effects of antiretroviral treatment are also discussed. The course is accredited by the HPCSA for CPD points and suits South African psychologists in health, neuropsychology and community settings who want more confidence identifying the cognitive implications of HIV.
This specialised talk , presented by experienced Clinical Neuropsychologist Digby Ormond-Brown, explores the neuropsychological impact of HIV, with a particular focus on HIV’s effects on brain function and cognition. The session begins with a concise overview of HIV pathophysiology, highlighting how the virus affects neurological structures.
Participants will gain a clear understanding of HIV-Associated Neurocognitive Disorder (HAND), including the spectrum of severity from asymptomatic neurocognitive impairment to HIV-associated dementia. Digby also outlines how HAND is identified and measured through neuropsychological assessment tools, and examines the role of biomarkers and the potential neuroprotective effects of antiretroviral treatment.
This talk is ideal for psychologists working in health, neuropsychology, or community settings who want to increase their confidence in identifying and understanding the cognitive implications of HIV.
Sections
Learning Outcomes
By the end of this talk, participants will be able to:
Describe how HIV affects the brain and cognition.
Understand the diagnostic criteria for HIV-Associated Neurocognitive Disorder (HAND).
Identify appropriate neuropsychological assessment methods for HAND.
Interpret the relevance of biomarkers in cognitive impairment related to HIV.
Consider the cognitive and neurological impact of antiretroviral therapy.